PT-141

PT-141, also known as bremelanotide, is a synthetic cyclic heptapeptide derived from the melanocortin peptide framework and investigated for its interaction with melanocortin receptors. In laboratory research, PT-141 may be studied to characterize receptor-mediated signaling, peptide-receptor interactions, and downstream cellular responses under controlled experimental conditions. Analytical characterization can include HPLC and mass spectrometry to evaluate peptide purity, molecular identity, and structural integrity. These studies provide a controlled framework for investigating melanocortin-related peptide signaling and molecular pharmacology. Strictly for laboratory research use only — not intended for human or veterinary use, therapeutic applications, or diagnostic purposes.